Dreman Value Management’s Elevance Health ELV Stock Holding History

Dreman Value Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.31M	Hold	5,949	–	–	0.59%	31
2017 Q4	$1.34M	Hold	5,949	–	–	0.75%	30
2017 Q3	$1.13M	Hold	5,949	–	–	0.62%	43
2017 Q2	$1.12M	Buy	5,949 +1,134	+24%	+$204K	0.62%	43
2017 Q1	$796K	Hold	4,815	–	–	0.46%	56
2016 Q4	$692K	Sell	4,815 -1,279	-21%	-$171K	0.39%	65
2016 Q3	$764K	Hold	6,094	–	–	0.46%	96
2016 Q2	$800K	Buy	6,094 +278	+5%	+$38K	0.49%	79
2016 Q1	$808K	Buy	+5,816	New	+$777K	0.09%	188
2015 Q4	–	Sell	-125	Closed	-$18K	–	256
2015 Q3	$18K	Buy	+125	New	+$18.8K	﹤0.01%	405
2014 Q4	–	Sell	-2,808	Closed	-$336K	–	483
2014 Q3	$336K	Sell	2,808 -105	-4%	-$12K	0.03%	245
2014 Q2	$313K	Buy	2,913 +446	+18%	+$46K	0.02%	258
2014 Q1	$246K	Buy	2,467 +170	+7%	+$15.4K	0.02%	246
2013 Q4	$212K	Buy	+2,297	New	+$204K	0.02%	269

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dreman Value Management's ELV Position: Q1 2018 in Review

Dreman Value Management held its Elevance Health (ELV) position steady in Q1 2018 at 5,949 shares worth $1.31M. The position accounts for 0.59% of the portfolio, ranked #31.

Dreman Value Management first reported a position in ELV in Q4 2013 and has held it in 14 quarters since. The position peaked at $1.34M in Q4 2017. 924 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

Dreman Value Management held 5,949 shares of Elevance Health worth $1.31M as of Q1 2018.
Dreman Value Management left its Elevance Health share count unchanged in Q1 2018.
Elevance Health made up 0.59% of Dreman Value Management's portfolio in Q1 2018, its #31 holding.
Dreman Value Management first reported a position in Elevance Health in Q4 2013 and has held it in 14 quarters since.
Dreman Value Management's Elevance Health position peaked at $1.34M in Q4 2017.
924 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.